Reaction
Fat Tissue Increased reporting signals
As of the last recalculation, Fat Tissue Increased appears in 1,433 FAERS reports alongside 31 co-occurring drug terms. The strongest observed disproportionality signal is NEVIRAPINE (PRR 37.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Nevirapine | 23 | 37.6 | 37.7 |
| Lopinavir And Ritonavir | 23 | 25.0 | 25.1 |
| Abaloparatide | 49 | 25.0 | 25.0 |
| Lamivudine | 44 | 21.3 | 21.3 |
| Lamivudine Oral | 35 | 20.6 | 20.6 |
| Atazanavir | 18 | 18.4 | 18.4 |
| Zidovudine | 15 | 16.5 | 16.5 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 11 | 16.0 | 16.0 |
| Abacavir Sulfate | 10 | 15.0 | 15.0 |
| Ritonavir | 28 | 14.2 | 14.2 |
| Ritonavir 100 Mg | 14 | 13.7 | 13.7 |
| Bendamustine Hcl | 14 | 13.2 | 13.2 |
| Efavirenz | 10 | 13.1 | 13.1 |
| Cabotegravir | 7 | 12.6 | 12.7 |
| Relugolix | 20 | 12.5 | 12.5 |
| Emtricitabine And Tenofovir Alafenamide | 9 | 11.6 | 11.6 |
| Darunavir | 11 | 10.6 | 10.6 |
| Raltegravir | 12 | 10.6 | 10.6 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 13 | 10.5 | 10.5 |
| Dolutegravir Sodium | 6 | 9.7 | 9.7 |
| Leuprolide Acetate | 42 | 8.1 | 8.1 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 23 | 7.4 | 7.4 |
| Asfotase Alfa | 5 | 7.3 | 7.3 |
| Vemurafenib | 5 | 6.1 | 6.1 |
| Teriparatide | 45 | 6.0 | 6.0 |
| Etonogestrel | 16 | 4.9 | 4.9 |
| Peginterferon Beta-1A | 4 | 4.4 | 4.4 |
| Apalutamide | 3 | 3.7 | 3.7 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 3 | 3.5 | 3.5 |
| Enzalutamide | 13 | 3.2 | 3.2 |
| Dulaglutide | 19 | 3.1 | 3.1 |